schedule13g.htm
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Schedule
13G
Under
the Securities Exchange Act of 1934
NYMOX
PHARMACEUTICAL CORPORATION
(Name
of Issuer)
Common
Shares
(Title
of Class of Securities)
67076P102
(CUSIP
Number)
February
7, 2008
(Date
of Event Which Requires Filing of this Statement)
Check the
appropriate box to designate the rule pursuant to which this Schedule is
filed:
[ ] Rule
13d-1(b)
[x] Rule
13d-1(c)
[ ] Rule
13d-1(d)
*The
remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No.
67076P102
1
|
Names
of Reporting Persons
I.R.S.
Identification Nos. of above persons (entities only).
Hal
Pettigrew
|
2
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [
x ]
|
3
|
SEC
Use Only
|
4
|
Citizenship
or Place of Organization
United
States of America
|
Number
of Shares
Beneficially
Owned
by Each
Reporting
Person
With:
|
5
|
Sole
Voting Power
732,460
|
6
|
Shared
Voting Power
800,500
|
7
|
Sole
Dispositive Power
732,460
|
8
|
Shared
Dispositive Power
800,500
|
9
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
1,532,960
|
10
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
|
11
|
Percent
of Class Represented by Amount in Row (9)
5.19%
|
12
|
Type
of Reporting Person (See Instructions)
IN
|
Item
1(a) Name
of Issuer:
Nymox
Pharmaceutical Corporation
Item
1(b)
|
Address
of Issuer’s Principal Executive
Offices:
|
9900 Cavendish Blvd.
St. Lauren, QC, Canada H4M
2V2
Item
2(a) Names
of Persons Filing:
Hal Pettigrew
Item
2(b) Address
of Principal Business Office or, if none, Residence:
2311
Cedar Springs Road, Suite 100, Dallas, Texas 75201
Item
2(c) Citizenship:
United States of America
Item
2(d) Title
of Class of Securities:
Common
Shares
Item
2(e) CUSIP
Number:
67076P102
Item
3.
|
If
this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or
(c), check whether the person filing is
a:
|
Not Applicable.
Item
4. Ownership
Provide the following information
regarding the aggregate number and percentage of the class of securities of the
issuer identified in Item 1.
(a) Amount Beneficially
Owned: 1,532,960 shares
|
(b)
|
Percent of
Class: 5.19%
|
|
(c)
|
Number of shares as to which
the person has:
|
(i) Sole
power to vote or to direct the vote
|
732,460
|
(ii) Shared
power to vote or to direct the vote
|
800,500
|
(iii) Sole
power to dispose or to direct the disposition of
|
732,460
|
(iv) Shared
power to dispose or to direct the disposition of
|
800,500
|
Item
5.
|
Ownership
of Five Percent or Less of a Class
|
If this
statement is being filed to report the fact that as of the date hereof the
reporting person has ceased to be the beneficial owner of more than five percent
of the class of securities, check the following [ ].
Item
6.
|
Ownership
of More than Five Percent on Behalf of Another
Person
|
The
reporting person beneficially owns an aggregate of 1,532,960 common shares (the
“Shares”) of the Issuer, which includes the following Shares in which the
reporting may be deemed to have shared voting or dispositive
power: (i) 603,500 Shares held in or managed by various trusts, of
which 593,000 Shares are held in trusts managed by a trustee other than the
reporting person, and 10,500 Shares are held by trusts in which the reporting
person is co-trustee, (ii) 167,000 Shares held by a profit sharing plan of which
the reporting person has an interest, and (iii) 30,000 Shares held by, or in a
trust for, the spouse of the reporting person, which trust is managed by a
trustee other than the reporting person. Except as otherwise set
forth herein, no other person or entity is known to have the right to receive or
the power to direct the receipt of dividends from, or the proceeds from the sale
of, the Shares.
Item
7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding Company or Control
Person
|
Not
Applicable.
Item
8.
|
Identification
and Classification of Members of the
Group
|
Not
Applicable.
Item
9.
|
Notice
of Dissolution of Group
|
Not
Applicable.
(a) Not
Applicable.
(b) By
signing below, I certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and
correct.
Dated: March
14, 2008
/s/ Hal
Pettigrew
Hal
Pettigrew